NCT00002751View on ClinicalTrials.gov

Monoclonal Antibody Therapy in Treating Patients With Brain Metastases

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

July 31, 1989

Study Completion Date

May 31, 2004

Conditions
Metastatic Cancer
Interventions
BIOLOGICAL

monoclonal antibody Me1-14 F(ab')2

Trial Locations (1)

27710

Duke Comprehensive Cancer Center, Durham

Sponsors

Lead Sponsor

Duke University
All Listed Sponsors
lead

Duke University

OTHER